Biosys Lab, a Venture from Fujita Health University, and Oizumi Purals Form Business Alliance to Expand Next-Generation Gut Health Products
Oizumi Purals, the developer of the health brand 'MyLOHAS,' has partnered with university venture Biosys Lab. By combining academic evidence from Fujita Health University with commercial product development, they aim to create science-backed intestinal health solutions and introduce internal gut health testing for employees.
📋 Article Processing Timeline
- 📰 Published: April 27, 2026 at 20:00
- 🔍 Collected: April 27, 2026 at 11:31
- 🤖 AI Analyzed: April 28, 2026 at 07:13 (19h 41m after Collected)
Oizumi Purals Co., Ltd. (Headquarters: Yamato City, Kanagawa; CEO: Yoshimasa Ogura), which develops and manufactures health foods such as 'gut health' products both in Japan and overseas, is pleased to announce a business alliance with Biosys Lab Co., Ltd., a venture company from Fujita Health University. This partnership will merge scientific expertise in intestinal health with the product development capabilities of the 'MyLOHAS GUT' brand to promote next-generation product development and information dissemination in the gut health sector.
Background of the Alliance
This alliance aims to integrate the product development power of Oizumi Purals' 'MyLOHAS GUT' brand with the academic expertise of Biosys Lab in the field of gut health. By scientifically investigating the mechanisms of various prebiotic and probiotic ingredients, the companies aim to expand a next-generation product lineup based on scientific evidence. Simultaneously, they will work to provide consumers with clearer 'evidence' (scientific proof). Through this collaboration, they strive to create new value that contributes to the healthier lives of individuals.
About Biosys Lab Co., Ltd.
Biosys Lab is a university-recognized gut health awareness venture established to share the research findings of Fujita Health University regarding prebiotics*1 and probiotics*2 with society. Through joint research projects with companies, they support multifaceted research areas including the prebiotic and probiotic domains, and assist in accelerating businesses utilizing the latest research information and functional ingredients.
*1: Ingredients that serve as food for beneficial bacteria in the gut.
*2: Live bacteria that provide beneficial effects for the body.
Comment from Takumi Tochio, CEO of Biosys Lab Co., Ltd.
'Biosys Lab is delighted to support the popularization of "gut health," including prebiotics and probiotics, together with Oizumi Purals. The product development power and consumer-oriented communication skills of Oizumi Purals' "MyLOHAS" brand hold great potential for creating new value in the gut health market. We will provide expertise on the intestinal environment and prebiotics to support product creation based on solid evidence. Through this partnership, we aim to deliver "easy-to-understand and reliable gut health" to more people, contributing to the further growth and market expansion of MyLOHAS. We have high expectations for our future challenges.'
Comment from Yoshimasa Ogura, CEO of Oizumi Purals Co., Ltd.
'We are very pleased to enter into a business alliance in the field of gut health with Biosys Lab, a pioneer in prebiotic and probiotic research. Our company has supported our customers' healthy daily lives through the development, manufacture, and sale of health foods while prioritizing "safety and security" and "effectiveness and realization." Through this alliance, by merging Biosys Lab's expertise in the latest research and functional ingredients with our product development and communication capabilities, we intend to disseminate products and information related to gut health based on more scientific evidence. Toward achieving our mission of "contributing to people's healthier lives" and Biosys Lab's goal of "creating a society where everyone in Japan consumes useful prebiotics and probiotics (Gut Health for 120 Million People)," we will further contribute to realizing wellness through gut health. Please look forward to the challenges of both companies.'
Considering the Introduction of 'Intestinal Environment Testing' as an Internal Welfare Benefit
As the first initiative of this business alliance, Oizumi Purals is proceeding with the introduction of a welfare benefit that allows employees to undergo 'intestinal environment testing.' This initiative aims to support employees' healthy lives and raise awareness of gut health, with the expectation that employees will discover new insights and deepen their understanding by practicing gut health themselves. Moving forward, using this welfare benefit as a starting point, the company plans to further expand efforts such as gut health support initiatives, events, and seminars.
About MyLOHAS
MyLOHAS is a health food brand that prioritizes 'safety and security' and focuses on 'assisting in extending healthy lifespan' and 'effective products based on evidence.' The brand develops products in various categories including MyLOHAS GUT (intestinal flora care), MyLOHAS SPORTS (sports), MyLOHAS STYLE (diet), and MyLOHAS WELLNESS (lifestyle).
Background of the Alliance
This alliance aims to integrate the product development power of Oizumi Purals' 'MyLOHAS GUT' brand with the academic expertise of Biosys Lab in the field of gut health. By scientifically investigating the mechanisms of various prebiotic and probiotic ingredients, the companies aim to expand a next-generation product lineup based on scientific evidence. Simultaneously, they will work to provide consumers with clearer 'evidence' (scientific proof). Through this collaboration, they strive to create new value that contributes to the healthier lives of individuals.
About Biosys Lab Co., Ltd.
Biosys Lab is a university-recognized gut health awareness venture established to share the research findings of Fujita Health University regarding prebiotics*1 and probiotics*2 with society. Through joint research projects with companies, they support multifaceted research areas including the prebiotic and probiotic domains, and assist in accelerating businesses utilizing the latest research information and functional ingredients.
*1: Ingredients that serve as food for beneficial bacteria in the gut.
*2: Live bacteria that provide beneficial effects for the body.
Comment from Takumi Tochio, CEO of Biosys Lab Co., Ltd.
'Biosys Lab is delighted to support the popularization of "gut health," including prebiotics and probiotics, together with Oizumi Purals. The product development power and consumer-oriented communication skills of Oizumi Purals' "MyLOHAS" brand hold great potential for creating new value in the gut health market. We will provide expertise on the intestinal environment and prebiotics to support product creation based on solid evidence. Through this partnership, we aim to deliver "easy-to-understand and reliable gut health" to more people, contributing to the further growth and market expansion of MyLOHAS. We have high expectations for our future challenges.'
Comment from Yoshimasa Ogura, CEO of Oizumi Purals Co., Ltd.
'We are very pleased to enter into a business alliance in the field of gut health with Biosys Lab, a pioneer in prebiotic and probiotic research. Our company has supported our customers' healthy daily lives through the development, manufacture, and sale of health foods while prioritizing "safety and security" and "effectiveness and realization." Through this alliance, by merging Biosys Lab's expertise in the latest research and functional ingredients with our product development and communication capabilities, we intend to disseminate products and information related to gut health based on more scientific evidence. Toward achieving our mission of "contributing to people's healthier lives" and Biosys Lab's goal of "creating a society where everyone in Japan consumes useful prebiotics and probiotics (Gut Health for 120 Million People)," we will further contribute to realizing wellness through gut health. Please look forward to the challenges of both companies.'
Considering the Introduction of 'Intestinal Environment Testing' as an Internal Welfare Benefit
As the first initiative of this business alliance, Oizumi Purals is proceeding with the introduction of a welfare benefit that allows employees to undergo 'intestinal environment testing.' This initiative aims to support employees' healthy lives and raise awareness of gut health, with the expectation that employees will discover new insights and deepen their understanding by practicing gut health themselves. Moving forward, using this welfare benefit as a starting point, the company plans to further expand efforts such as gut health support initiatives, events, and seminars.
About MyLOHAS
MyLOHAS is a health food brand that prioritizes 'safety and security' and focuses on 'assisting in extending healthy lifespan' and 'effective products based on evidence.' The brand develops products in various categories including MyLOHAS GUT (intestinal flora care), MyLOHAS SPORTS (sports), MyLOHAS STYLE (diet), and MyLOHAS WELLNESS (lifestyle).